info@imoveflu.org

Login

Published articles

Published I-MOVE articles

Below is a list of I-MOVE published articles, both at study site and at pooled level. Please see also the I-MOVE protocols and the scientific communications page. If you would like to let us know about an I-MOVE published article, please contact us.

  • Rose A, Kissling E, Emborg H-D, Larrauri A, McMenamin J, Pozo F et al. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020. Euro Surveil. 2020;25(10):pii=2000153. https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000153.

  • Rose AMC, Kissling E, Gherasim A, Casado I, Bella A, Launay O, et al. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017–18: A season of B lineage mismatched to the trivalent vaccine. Influenza Other Respir Viruses. 2020 Feb 5; doi: 10.1111/irv.12714. [Epub ahead of print]

  • Kissling E, Pozo F, Buda S, Vilcu AM, Gherasim A, et al. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort. Euro Surveill. 2019;24(48):pii=1900604. https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900604
  • Machado A, Mazagatos C, Dijkstra F, Kislaya I, Gherasim A, McDonald SA, et al. Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons. Euro Surveill. 2019;24(45):pii=1900268.
  • Pițigoi D, Nițescu M, Streinu-Cercel A, Bacruban R, Ivanciuc AE, Lazăr M, Cherciu CM, Crăciun MD, Aramă V, Streinu-Cercel A, Săndulescu O. Characteristics of influenza in elderly patients with and without diabetes, hospitalized for severe acute respiratory infection in a tertiary care hospital from Bucharest Romania – a three-year prospective epidemiological surveillance study. Germs 2019;9(3):142-147. doi: 10.18683/germs.2019.1169
  • Lazăr M, Mihai M.E, Cherciu C, Pascu C, Stoian E. 2018/19 Influenza Vaccine effectiveness in Romania in a season with Influenza A subtypes circulating, Roum Arch Microbiol Immunol, volume 78, pag 124-134, Issue 2 April – June 2019
  • Kissling E, Pozo F, Buda S, Vilcu AM, Rizzo C, Gherasim A, et al. Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18). Vaccine X. 2019;3:100042.
  • Martínez-Baz I, Navascués A, Casado I, Aguinaga A, Ezpeleta C, Castilla H. Remaining effect of influenza vaccines received in prior seasons. J Infect Dis 2019;220(7):1136-1140. https://doi.org/10.1093/infdis/jiz266
  • Bella A, Gesualdo F, Orsi A, et al. Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017–2018 season. Expert Review of Vaccines, DOI: 10.1080/14760584.2019.1627206
  • Kissling E, Rose A, Emborg HD, Gherasim A, Pebody R, Pozo F, et al., European IVE group. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill.2019;24(8):pii=1900121. https://doi.org/10.2807/1560-7917.ES.2019.24.1900121
  • Navascués A, Casado I, Pérez-García A, Aguinaga A, Martínez-Baz I, Floristán Y, et al. Detection of respiratory viruses in deceased persons. Spain 2017. Emerg Infect Dis.2018:24(7) 1331-1334.
  • Pebody RG, Sinnathamby MA, Warburton F, Andrews N, Boddington NL, Zhao H, et al. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16. Euro Surveill.2018;23(25):pii=1700496. https://doi.org/10.2807/1560-7917.ES.2018.23.25.1700496
  • Paradowska-Stankiewicz I, Korczyńska MR, Cieślak K, Kowalczyk D, Szymański K, Brydak LB. Vaccine effectiveness against influenza in 2015/16 in hospital and ambulatory medical care facilities: Polish results of the European I-MOVE + Multicenter Study”. Adv Exper Med Biol 2018;1023:93-100.
  • Machado A, Kislaya I, Guiomar R, Nunes B. Moderate influenza vaccine effectiveness in a B mismatch season: preliminary results from the 2017/2018 season in Portugal. Pulmonology 2018;24(4);260-262. https://doi.org/10.1016/j.pulmoe.2018.05.004.
  • Valenciano M, Kissling E, Larrauri A, Nunes B, Pitigoi D, O Donnell J, et al, I-MOVE primary care multicentre case-control team. Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17. Influenza Other Respir Viruses. 2018;1-15.doi: 10.1111/irv.12562.
  • Rondy M, Kissling E, Emborg H-D, Gherasim A, Pebody R, Trebbien R, et al, I-MOVE/I-MOVE+ group. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018;23(9):pii=18-00086
  • Casado I, Dominguez A, Toledo D et al. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case–control study. CMAJ 2018 January 8;190:E3-12. doi: 10.1503/cmaj.170910
  • Castilla J, Martínez-Baz I, Navascués A et al. Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16. Euro Surveill. 2018;23(2):pii=16-00780. https://doi.org/10.2807/1560-7917.ES.2018.23.2.16-00780
  • Kissling E, Valenciano M, Pozo F, Vilcu A-M, Reuss A, Rizzo C, et al, I-MOVE/I-MOVE+ study team, 2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children. Influenza Other Resp Viruses. Accepted Author Manuscript.doi:10.1111/irv.125207.
  • Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, et al. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Euro Surveill. 2017;22(44):pii=17-00306. https://doi.org/10.2807/1560-7917.ES.2017.22.44.17-00306
  • Sout C, et al. Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France. J Clin Virol, 2017. 95: p. 1-4.
  • Vilcu AM, et al. Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method. Clin Microbiol Infect, 2017.
  • Teirlinck AC, van Asten L, Brandsema PS, Dijkstra F, Donker GA, van Gageldonk-Lafeber AB, et al. Annual report surveillance of influenza and other respiratory infections in the Netherlands: winter 2016/2017. RIVM report number: 2017-0096, Bilthoven, 2017.
  • Gherasim A, Martínez-Baz I, Castilla J, Pozo F, Larrauri A; cycEVA working group. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain. PLoS One. 2017 Jun14;12(6):e0179160
  • Kissling E, Rondy M, I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017;22(7):pii=30464. DOI: https://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464
  • Castilla J, Navascués A, Casado I, Díaz-González J, Pérez-García A, Fernandino L, et al., Primary Health Care Sentinel Network, Network for Influenza Surveillance in Hospitals of Navarre. Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis. Euro Surveill. 2017;22(7):pii=30465. DOI: https://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30465
  • Martínez-Baz I, Casado I, Navascués A, Díaz-González J, Aguinaga A, Barrado L, et al. Effect of repeated vaccination with the same vaccine component against influenza A(H1N1)pdm09.J Infect Dis. 2017
  • Gómez V, Guiomar R, Rodrigues AP, Pechirra P, Conde P, Cristóvão P, et al. Efetividade da vacina antigripal na época 2015-2016 em Portugal: resultados do projeto EuroEVA. Boletim Epidemiológico Observações. 2016;16:16-19
  • Reuß A, Preuß U: Wirksamkeit der Impfung gegen saisonale Influenza (Impfeffektivität) in Buda, S, Köpke, K, Prahm, K et al. Bericht zur Epidemiologie der Influenza in Deutschland Saison 2015/16. Robert Koch-Institut.
  • Castilla J, Navascués A, Fernández-Alonso M, Reina G, Pozo F, Casado I, et al.; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarra. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. Vaccine. 2016 ;34:1350-7.
  • Castilla J, Navascués A, Fernández-Alonso M, Reina G, Albéniz E, Pozo F, et al.; Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season. Euro Surveill. 2016 Jun 2;20(22). doi: 10.2807/1560-7917.ES.2016.21.22.30243.
  • Rizzo C, Bella A, Alfonsi V, Puzelli S, Palmieri AP et al. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season. Vaccine (in-press, uncorrected proof).
  • Hallmann-Szelińska E, Bednarska K, Korczyńska M, Paradowska-Stankiewicz I, Brydak LB. Virological characteristics of the 2014/2015 influenza season based on molecular analysis of biological material derived from I-MOVE Study”, Advs Exp Med, Biol – Neurosci Respir. DOI 10.1007/5584_2016_236.
  • Kissling E, Nunes B, Robertson C, Valenciano M, Reuss A, Larrauri A, et al, I-MOVE case–control study team. I-MOVE multicentre case–control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Euro Surveill. 2016;21(16):pii=30201. DOI: https://dx.doi.org/10.2807/1560-7917.ES.2016.21.16.30201
  • Gherasim A, Pozo F, de Mateo S, Aspirtxaga I, García-Cenoz M, Vega T, et al., VEVA Working group. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. Vaccine 2016:34(20), 2371–7
  • Oroszi B, Horvath JK, Ferenczi A, Hercegh E. Case-control study to measure influenza vaccine effectiveness during the 2014-15 influenza season in Hungary. Central European Journal of Occupational and Environmental Medicine 2015; 21 (3-4); 117.
  • Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth J, et al., on behalf of the I-MOVE multicentre case–control team. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case–Control Study, Europe 2014/15. Euro Surveill. 2016;21(7):pii=30139. DOI: https://dx.doi.org/10.2807/1560-7917.ES.2016.21.7.30139
  • Kissling E, Valenciano M. Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. Euro Surveill. 2016;21(6):pii=30134. DOI: https://dx.doi.org/10.2807/1560-7917.ES.2016.21.6.30134
  • Castilla J, Navasucués A, Fernández-Alonso M, Reina G et al. Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous season. Vaccine 2016. 34(11) 1350-7. https://dx.doi.org/10.1016/j.vaccine.2016.01.054
  • Casado I, Martínez-Baz I,Floristán Y, Chamorro J, Ezpeleta C, Castilla J, Network of Influenza Surveillance n Hospitals of Navarra. Cause of death in hospitalized patients with laboratory-confirmed influenza. An. Sist. Sanit. Navar. 2015; 38 (2) (ahead of Pub)
  • Castilla J, Guevara M, Martínez-Baz I,  Ezpeleta C, Delfrade J, Irisarri F, et al. Enhanced estimates of the influenza vaccination effect in preventing mortality: A prospective cohort study. Medicine 2015; 94(30):e1240
  • Jimenez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, et al., On behalf of The Spanish Influenza Sentinel Surveillance System C. Euro Surveill. 2015 Jul 16;20(28). pii: 21187
  • Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horvath JK, O’Donell JM, et al. The European I-MOVE Multicentre 2013–2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015 Jun 4;33(24):2813-22. doi: 10.1016/j.vaccine.2015.04.012. Epub 2015 Apr 28
  • Martínez-Baz I, Navascués A, Pozo F, Chamorro J, Albeniz E, Casado I, et al., Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccin Immunother. 2015 Jul 3;11(7):1626-33. doi: 10.1080/21645515.2015.1038002.
  • Jiménez-Jorge S, Pozo F, Larrauri A, de Mateo S, Delgado-Sanz C, Casas I, et al. Study Team. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the last four seasons 2010-2014.Vaccine. 2015 Jun 26;33(29):3276-80. doi: 10.1016/j.vaccine.2015.03.051. Epub 2015 Apr 11.
  • Pebody RG, Warburton F, Ellis J, Andrews N, Thompson C, von Wissmann B, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results. Euro Surveill. 2015;20(5):pii=21025.
  • Pitigoi D, Necula G, Alexandrescu V, Mihai ME, Cherciu CM, Tecu C, et al. Circulating influenza viruses and the effectiveness of seasonal influenza vaccine in Romania, season 2012-2013. Rev Romana Med Lab. 2015;23(1):9-20. DOI:10.1515/rrlm-2015-0007
  • Simpson CR, Lone NI, Kavanagh K, Ritchie LD, Robertson C, Sheikh A, et al. Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009. Euro Surveill. 2015;20(8):pii=21043.
  • Casado I, Martínez-Baz I, Burgui R, Irisarri F, ArriazuM, Elía F, et al., Primary Health CareSentinel Network of Navarra. Household transmission of influenza A(H1N1)pdm09in the pandemic and post-pandemic seasons. PLoS One. 2014 Sep 25;9(9)
  • Jiménez-Jorge S, de Mateo Ontañón S, Savulescu C, Delgado Sanz C, Pozo Sánchez F, Larrauri A et al. Estudio cycEVA: casos y controles para la estimación de la efectividad de la vacuna antigripal en España, 2008-2013. Rev Esp Salud Pública 2014; 88:601-11
  • Andrews N, McMenamin J, Durnall H, Ellis Lackenby A, Robertson C, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill. 2014;19(27):pii=20851.
  • Martínez-Baz I, Guevara M, Elía F, Ezpeleta C, FernándezAlonso M, Castilla J.[Influence of distinct criteria for selecting patients for swabbing on estimationof the effectiveness of the influenza vaccine]. GacSanit. 2014 May-Jun;28(3):225-9. doi: 10.1016/j.gaceta.2013.09.007.Epub 2013 Dec 4. Spanish.PubMed PMID: 24315408
  • Nunes B, Machado A, Guiomar R, Pechirra P, Conde P, Cristovao P, et al. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with diffierent influenza negative control groups. Vaccine 2014. DOI: 10.1016/j.vaccine.2014.06.053
  • Savulescu C, Jiménez-Jorge S, Delgado-Sanz, de Mateo S, Pozo F, Casas I, et al. Higher vaccine effectiveness in seasons with predominant circulation of seasonal A(H1N1) than in A(H3N2) seasons: Test-negative case-control studies using surveillance data, Spain, 2003-2011. Vaccine 2014 . DOI: 10.1016/j.vaccine.2014.06.063
  • Jiménez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, García-Cenoz M, et al., on behalf of the Spanish Influenza Sentinel Surveillance System (SISS). Influenza vaccine effectiveness in Spain2013/14: subtype-specific early estimates using the cycEVA study. EuroSurveill. 2014;19(9):pii=20727.
  • Castilla J, I Martínez-Baz, A Navascués, M Fernández Alonso et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill. 2014;19(6):pii=20700
  • Kissling E, Valenciano M, Buchholz U, Larrauri A et al. Influenza vaccine effectiveness estimates in Europe in a season with three different influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014;19(6):pii=20701.
  • Simpson CR, Lone N, Kavanagh K, Ritchie LD, Robertson C, Sheikh A, et al. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study -exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccin
  • Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, García Cenoz M, et al. Effectiveness of influenza vaccine agains laboratory-confirmed influenaza, in the late 2011-13 season in Spain, among population targeted for vaccination. BMC Infect Dis. 2013 Sep 22;13(1):441.
  • Robert Koch Study team. Zur Effektivität der Influenza-Impfung gegen saisonale Influenza in der Saison 2012/2013. Epidemoilogisches Bulletin Sept 2013: 38
  • Martínez-Baz I, Martínez-Artola V, Reina G, Guevara M, Cenoz MG, Morán J, et al., Primary Health Care Sentinel Network of Navarre.Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health. 2013 Mar 6;13:191. doi: 10.1186/1471-2458-13-191.
  • Valenciano M, Kissling E, I-MOVE case-control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case–control study, 2012/13. . Euro Surveill. 2013;18(7):pii=20400.
  • Castilla J, Martínez-Baz I, Martínez-Artola V, Fernández-Alonso M, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill. 2013;18(7):pii=20404
  • McMenamin J, Andrews N, Robertson C, Fleming D.M, Durnall H et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13. Euro.Surveill. 2013;18(5).
  • Pebody R.G, Andrews N, McMenamin J, Duranll H, Ellis J et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill. 2013;18(5).
  • Castilla J, Martínez-Baz I, Martínez-Arola V, Reina G, Pozo F et al. Decline in influenza vaccine effectiveness iwth time after vaccination, Navarre, Spain, season 2011/12. Euro.Surveill.2013;18(5).
  • Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from teh I-MOVE multicentre case-control study Euro.Surveill.2013;18(5).
  • Valenciano M, Ciancio BC, on behalf of the I-MOVE study team. I-MOVE a European network to measure the effectiveness of influenza vaccines. Euro Surveilance.2012;17(39):pii=20281.
  • Nunes B, Machado A, Pechirra P, Falcao I, Gonçalves P, Conde P, et al. Efetividade da vacina antigripal na época 2010-2011 em Portugal: resultados do projeto EuroEVA. Rev Por Med Geral Fam 2012;28:271-84.
  • Pitigoi D, Ivanciuc AE, Necula G, Lupulescu E, Alexandrescu V, Savulescu C. Influenza vaccine effectiveness to prevent medically attended laboratory confirmed influenza during season 2010-2011 in Romania: a case control study, Revista Romana de Medicina de Laborator Vol 20, Nr. 2/4, June 2012
  • Robert Koch Study team. Wirksamkeit der Influenza-Impfung gegen saisonaleInfluenza A(H3N2) in der Saison 2011/2012. Epidemoilogisches Bulletin Oct 2012;41.
  • Jiménez-JorgeS, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, et al. The cycEVA Study Team; on behalf of the Spanish Influenza Sentinel Surveillance System.Effectivenessof the 2010–11 seasonal trivalent influenza vaccine in Spain: cycEVA study. 2012, Vaccine:https://dx.doi.org/10.1016/j.vaccine.2012.03.048.
  • E Kissling, M Valenciano, I-MOVE case–control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case–control study, 2011/12. Euro Surveill. 2012;17(15)
  • J Castilla, F Cía, J Zubicoa, G Reina, V Martínez-Artola, C Ezpeleta. Influenza outbreaks in nursing homes with high vaccination coverage in Navarre, Spain, 2011/12 Euro Surveill. 2012:17(14)
  • S Jiménez-Jorge, S de Mateo, F Pozo, I Casas et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill. 2012;17(12)
  • Barret AS, O´Donnell J, O´Hara A, Collins C, Coughlan S, Joyce M, et al. Effectiveness of 2010/11 Seasonal Influenza Vaccine in Ireland. The Irish Medical Journal. Fev 2012;105(2)
  • Kavanagh K, Robertson C, McMenamin J. Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on OUtcome and Methodological Approach. PLoS ONE 6(12): e28743. doi:10.1371/journal.pone.0028743.
  • Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: Results from a cohort study in general practice. Vaccine. 2011 Dec 15.
  • Savulescu C, Jimenez-Jorge S, de Mateo S, Pozo F, Casas I, Perez Brena P, et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case control studies, Spain, season 2009-2010. BMC Public Health. 2011 Nov 30;11(1):899.
  • Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and stratified estimates of influenza vaccine effectiveness in Europe. Plos-ONE 6(11).
  • Castilla J, Martínez-Artola V, Salcedo E, Martínez-Baz I, Cenoz MG, Guevara M, et al., Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: Cohort and case-control study. Vaccine. 2011 Nov 17. PubMed PMID: 22100636.
  • Seyler T, Bella A, Puzelli S, Donatelli I, Rizzo C. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010. Vaccine. 2011 Nov 16. Pubmed PMID:22100893
  • Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, et al., The Primary Health Care Sentinel Network of Navarre. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. 2011 Aug 11;29(35):5919-24. Epub 2011 Jun 30.
  • Kissling E, Valenciano M, I-MOVE case–control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case–control study. Euro Surveill. 2011;16(11):pii=19818
  • Savulescu C, Jiménez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, et al., cycEVA Study Team. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case–control study. Euro Surveill. 2011;16(11):pii=19820.
  • Pebody R, Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11 . Euro Surveill. 2011;16(6):pii=19791.
  • Castilla J, Morán J, Martínez-Artola V, Reinga G, Martínez-Baz I, García Cenoz M, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill. 2011;16(7):pii=19799
  • Larrauri A, Savulescu C, Jiménez-Jorge S, Pérez-Breña P, Pozo F, Casas I, et al. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalente vaccine against pandemic influenza in Spain. Gac Sanit. 2011 25(1):23-8.
  • Hardelid P et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011;16(2):pii=19763. Available online: https://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763
  • Valenciano M et al. Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study. Plos Med8(1):e10000388.doi;10.1371/journal.pmed.1000388
  • Ed Belongia comments results from Multicentre Case-Control
    Castilla J, Guevara M, Garcia Cenoz M, Irisarri F, Arriazu M, Baricarte A, et al. Impact of vaccination against Influenza (H1N1)2009 in Navarre: comparision of different scenarii (in Spanish). Rev Esp Salud Pública 2011; 84:113-11
  • Castilla J, Morán J, Fernández-Alonso M, Martínez Artola V, Zamora MJ, Mazón A, et al. The 2009 H1N1 pandemic in Navarre, Spain (in Spanish). An Sist Sanit Navar 2010;33;287-295.
  • Castilla J, Guevara M, García Cenoz M, Reina G, Martínez Artola V, Zamora MJ, et al. Differences between summer and fall waves of influenza in the pandemic (H1N1) 2009 in Navarre, Spain (in Spanish). Rev Esp Salud Pública 2011; 85: 55-64
  • Savulescu et al. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network–pilot case-control studies using different control groups, 2008-2009 season, Spain.Vaccine. 2010 Apr 1;28(16):2903-7.
  • Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010 Oct 28;28(46):7381-8
  • Irish team, Information for GPs: Barret AS et al. A Effectiveness of swine flu vaccine measured. Forum Reserach (journal of the Irish College of General Practitioners). Oc 2010.
  • Kissling et al. “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: Lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill. 2009;14(44):pii=19015388
  • Pitigoi et al. [Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009]. Bacteriol Virusol Parazitol Epidemiol. 2009 Apr-Jun;54(2):109-16. Romanian.
  • Denmark: EPI-NEWS, June 2009
  • Portugal: Observacoes, June 2009
  • Valenciano M et al. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveill. 2008 Oct 23;13(43)